AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HRSA Launches Survey on Adult and Adolescent ARV Guidelines
The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey to receive feedback on experiences with the guidelines.  The target audience are those staff that utilize the HIV treatment guidelines such as physicians, nurses, physician assistants (PAs), etc. It takes less than 15 minutes to complete the survey, and all respon...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

Updates to the CMV (Herpes Virus) Section of the Adult OI Guidelines
This revision provides guidance for the management of cytomegalovirus (CMV) retinitis, which develops or worsens in the setting of ART initiation. Data supporting the treatment of CMV retinitis with systemic anti-CMV therapy for prevention of contralateral eye and visceral disease are discussed.   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

FDA Approves Genvoya (a Fixed-Dose Combination Tablet) to Treat HIV Infection
“The U.S. Food and Drug Administration today [November 5, 2015] approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. …   “Genvoya is approved for use in HIV-infected adults and children ages 12 years and older weighing at least 35 kilograms (77 pounds) who have never taken HIV therapy (treatment-naïve) and HIV-infected adults whose HIV-1 virus is currently suppressed. While Genvoya is not recommended fo...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from HHS and NIAID
From HHS: October 21, 2015: HHS Awards $2.2 Billion in Grants for HIV/AIDS Care and Medications From NIAID: October 21, 2015: Immune Responses Provide Clues for HIV Vaccine Development October 20, 2015: HIV Cure Research: NIH Scientists Create Two-Headed Protein to Deplete HIV Reservoir (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

infoSIDA is on Twitter!
infoSIDA recently launched its own Spanish-language Twitter account. Previously, Spanish tweets would be posted on occasion on the @AIDSinfo Twitter account. Now, with its own account, infoSIDA will tweet daily to connect the Hispanic/Latino community with HIV/AIDS information. This account will provide followers with health tips and links to resources and news articles in Spanish. To view Spanish-language tweets about HIV/AIDS, follow @infoSIDA on Twitter today. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

Updated AIDSinfo Consumer Fact Sheets Offer an Overview of HIV
The updated AIDSinfo consumer fact sheets provide an introduction to HIV, including the basics of HIV prevention, transmission, and treatment. Each fact sheet includes a summary of key points and links to additional information. View or download the following updated fact sheets: The Basics of HIV Prevention HIV/AIDS: The Basics The HIV Life Cycle The Stages of HIV Infection HIV Testing HIV/AIDS Clinical Trials Visit infoSIDA to view the fact sheets in Spanish. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 23, 2015 Category: Infectious Diseases Source Type: news

Limited Access to Pyrimethamine Prompts Update of Toxoplasmosis Section of the Adult and Adolescent OI Guidelines
The Toxoplasma gondii Encephalitis section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents has been updated to provide clinicians with guidance on the use of trimethoprim-sulfamethoxazole for treatment of acute infection and chronic maintenance therapy for suspected or documented toxoplasmosis if pyrimethamine is not readily available.   On September 10, 2015, the OI Guidelines author panel issued this Notice of Availability of Pyrimethamine, which is guidance on what to do if pyrimethamine is unavailable to treat or prevent Toxoplasma encephalitis,...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 19, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC and NIH
From CDC: September 30, 2015: CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines   From NIH: September 30, 2015: Drug Used to Treat HIV Linked to Lower Bone Mass in Newborns (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

October 15 is National Latino AIDS Awareness Day
. This observance serves to heighten awareness of the disproportionate burden of HIV among Hispanics/Latinos. According to the Centers for Disease Control and Prevention (CDC), the estimated new HIV infection rate among Hispanics/Latinos in 2010 in the United States was more than 3 times as high as that of whites.   Visit our National Latino AIDS Awareness Day webpage [en español] to learn more about HIV in the Hispanic/Latino population. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

FDA Updates Atazanavir Oral Powder Label
"On September 24, 2015, FDA approved revisions to the Reyataz (atazanavir) oral powder label to include dosing recommendations for patients three months and older weighing at least 5 kg. This represents the addition of a new pediatric weight band. Previously the oral powder formulation was for patients three months and older weighing at least 10 kg.   "Reyataz oral powder must be taken with ritonavir and is not recommended for use in children who weigh less than 5 kg."   The updated labeling will be available at the FDA website.   More information is available: FDA: Press release AIDSinfo: Patient f...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 9, 2015 Category: Infectious Diseases Source Type: news

September 27 is National Gay Men’s HIV/AIDS Awareness Day
On September 27, join AIDSinfo in observing National Gay Men’s HIV/AIDS Awareness Day.   No group in the United States is more affected by HIV than gay and bisexual men. According to the Centers for Disease Control and Prevention (CDC), in 2013 in the United States, gay and bisexual men accounted for 65% of the 47,352 estimated HIV diagnoses among all people receiving an HIV diagnosis that year. In the same year, gay and bisexual men accounted for 55% of the estimated number of persons diagnosed with AIDS among all adults and adolescents in the United States.   Visit our National Gay Men’s HIV/AIDS Aw...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

NLM Releases Redesigned, Mobile-Optimized HIV/AIDS Information Website, Now Called AIDSource
The National Library of Medicine’s web portal for HIV/AIDS information has been redesigned and given a new name. The new website, AIDSource, offers access to a comprehensive collection of HIV/AIDS-related resources reviewed and selected by expert information specialists and librarians.   Visitors to the AIDSource website will now be able to view the website content on any device that they are using, as the website is now automatically optimized for display across all device types, including desktop computers, tablets, and smartphones. Feedback received through a website survey conducted in 2014 informed changes ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

Guideline Updates: Adult & Adolescent OI Guideline
Authors of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently released updates to the following sections: HPV - This update provides new recommendations regarding the cervical cancer screening interval for HIV-positive women after 3 consecutive normal Pap tests, and the use of HPV co-testing among HIV-positive  women >30 years of age. It additionally includes recommendations regarding the use of 9-valent HPV vaccine among HIV-positive females and males ages 9-26 to prevent HPV infection. HSV - This update provides new information...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 25, 2015 Category: Infectious Diseases Source Type: news

September 18 is National HIV/AIDS and Aging Awareness Day
The importance of National HIV/AIDS and Aging Awareness Day increases as the number of people aged 50 and older who are living with HIV continues to grow. According to the Centers for Disease Control and Prevention (CDC), people aged 55 and older accounted for 26% of the estimated 1.2 million people living with HIV infection in the United States in 2011.   Browse our National HIV/AIDS and Aging Awareness Day webpage [en español] to find resources and in-depth information about HIV and aging. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Ser...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news

Availability of Pyrimethamine: Statement from Adult & Adolescent OI Guideline Panel
Pyrimethamine is recommended for treatment and/or prophylaxis of Toxoplasma encephalitis, Pneumocystis pneumonia, and Isospora infection. As of June 2015, pyrimethamine is no longer available in retail pharmacies in the United States. It is only available through a special pharmacy program (http://www.daraprimdirect.com/how-to-prescribe). If there is a delay in procuring pyrimethamine for a patient in whom it is needed for one of the above indications, please refer to the specific pathogen section for alternative drug regimens for treatment or prophylaxis. For patients with suspected or documented toxoplasmosis who do not ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news